Clinical Trial Update: Rituximab After Autologous Stem Cell Transplant for Relapsed B-cell Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluating rituximab after autologous stem cell transplant in relapsed B-cell non-Hodgkin lymphoma have been completed, with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Lymphoma
• Mantle Cell Lymphoma
• Non-hodgkin Lymphoma
• Transformed Lymphoma

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Stanford University | Conditions: Non-Hodgkin's Lymphoma, Diffuse Large Cell Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2014-09-05